Cargando…

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?

The prototype cysteinyl leukotriene receptor antagonist, montelukast, is generally considered to have a niche application in the therapy of exercise- and aspirin-induced asthma. It is also used as add-on therapy in patients whose asthma is poorly controlled with inhaled corticosteroid monotherapy, o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tintinger, Gregory R., Feldman, Charles, Theron, Annette J., Anderson, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2010
Materias:	Mini-Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763941/ https://www.ncbi.nlm.nih.gov/pubmed/21170491 http://dx.doi.org/10.1100/tsw.2010.229

Ejemplares similares

Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
por: Theron, A. J., et al.
Publicado: (2014)

Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats
por: Otunctemur, Alper, et al.
Publicado: (2015)

Cysteinyl Leukotrienes and Their Receptors; Emerging Concepts
por: Kanaoka, Yoshihide, et al.
Publicado: (2014)

Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Induces M2 Macrophage Polarization and Inhibits Murine Aortic Aneurysm Formation
por: Kawai, Yohei, et al.
Publicado: (2019)

Cysteinyl-Leukotriene Receptors and Cellular Signals
por: Rovati, G. Enrico, et al.
Publicado: (2007)

Montelukast Inhibits Lung Cancer Cell Migration by Suppressing Cysteinyl Leukotriene Receptor 1 Expression In vitro
por: Chen, Yisheng, et al.
Publicado: (2023)

Formoterol is more effective than salmeterol in suppressing neutrophil reactivity
por: Tintinger, Gregory R., et al.
Publicado: (2015)

Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
por: Kemp, James P
Publicado: (2009)

Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

Cysteinyl Leukotriene Pathway and Cancer
por: Tsai, Ming-Ju, et al.
Publicado: (2021)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
por: Wallin, Johan, et al.
Publicado: (2021)

Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
por: Aigner, Ludwig, et al.
Publicado: (2020)

Structure based virtual screening of ligands to identify cysteinyl leukotriene receptor 1 antagonist
por: Bandaru, Srinivas, et al.
Publicado: (2014)

Cysteinyl leukotriene receptor antagonist regulates allergic airway inflammation in an organ- and cytokine-specific manner
por: Kawano, Tetsuya, et al.
Publicado: (2014)

Adipokines and Cysteinyl Leukotrienes in the Pathogenesis of Asthma
por: Coffey, Michael J., et al.
Publicado: (2015)

Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis
por: Peters-Golden, M, et al.
Publicado: (2006)

Regulation of dendritic cell functions against harmful respiratory pathogens by a cysteinyl leukotrienes receptor antagonist
por: Matsuse, Hiroto, et al.
Publicado: (2012)

MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication
por: Ruiz, Isaac, et al.
Publicado: (2020)

Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study
por: Jang, Ha Young, et al.
Publicado: (2022)

Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
por: Gelosa, Paolo, et al.
Publicado: (2017)

Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases
por: Colazzo, Francesca, et al.
Publicado: (2017)

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control
por: Noronha, Letícia Paula Trajano, et al.
Publicado: (2023)

Cysteinyl Leukotriene and Systemic Inflammatory Levels in Preeclampsia
por: Guzeltas, Gokhan, et al.
Publicado: (2023)

Cysteinyl Leukotrienes and Uridine Diphosphate Induce Cytokine Generation by Human Mast Cells Through an Interleukin 4–regulated Pathway that Is Inhibited by Leukotriene Receptor Antagonists
por: Mellor, Elizabeth A., et al.
Publicado: (2002)

Characterisation of P2Y(12) Receptor Responsiveness to Cysteinyl Leukotrienes
por: Foster, Holly R., et al.
Publicado: (2013)

Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors
por: Gusach, Anastasiia, et al.
Publicado: (2019)

Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs
por: Luginina, Aleksandra, et al.
Publicado: (2019)

Cysteinyl leukotriene receptor 1 is dispensable for osteoclast differentiation and bone resorption
por: Fujita, Hirofumi, et al.
Publicado: (2022)

The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
por: Michael, Johanna, et al.
Publicado: (2021)

Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
por: Theron, Annette J, et al.
Publicado: (2013)

Multifaceted Roles of Cysteinyl Leukotrienes in Eliciting Eosinophil Granule Protein Secretion
por: Baptista-dos-Reis, Renata, et al.
Publicado: (2015)

Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm
por: Di Gennaro, Antonio, et al.
Publicado: (2018)

Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
por: Marques, Cátia F., et al.
Publicado: (2022)

Differential Regulation of Cysteinyl Leukotriene Receptor Signaling by Protein Kinase C in Human Mast Cells
por: Kondeti, Vinay, et al.
Publicado: (2013)

170 Combination of a Nasal Antihistamine Olopatadine and A Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients not Currently Controlled on Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist
por: Nsouli, Safa
Publicado: (2012)

Regulation of Cysteinyl Leukotriene Receptor 2 Expression—A Potential Anti-Tumor Mechanism
por: Magnusson, Cecilia, et al.
Publicado: (2011)

Cysteinyl leukotriene receptor 1 modulates autophagic activity in retinal pigment epithelial cells
por: Koller, Andreas, et al.
Publicado: (2020)

The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
por: Marschallinger, Julia, et al.
Publicado: (2020)

Leukotriene E(4) is a full functional agonist for human cysteinyl leukotriene type 1 receptor-dependent gene expression
por: Foster, Holly R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nfi9upebcje55hl3o486spvmmu